MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome.

Knapp, Stephen T; Revette, Anna; Underhill-Blazey, Meghan; Stopfer, Jill E; Ukaegbu, Chinedu I; Poulin, Cole; Parenteau, Madison; Syngal, Sapna; Bae, Eunchan; Bickmore, Timothy; Hampel, Heather; Idos, Gregory E; Parmigiani, Giovanni; Yurgelun, Matthew B; Braun, Danielle

Knapp, Stephen T; Revette, Anna; Underhill-Blazey, Meghan; Stopfer, Jill E; Ukaegbu, Chinedu I; Poulin, Cole; Parenteau, Madison; Syngal, Sapna; Bae, Eunchan; Bickmore, Timothy; Hampel, Heather; Idos, Gregory E; Parmigiani, Giovanni; Yurgelun, Matthew B; Braun, Danielle.

Afiliação

Knapp ST; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Revette A; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Underhill-Blazey M; University of Rochester School of Nursing, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Stopfer JE; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Ukaegbu CI; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Poulin C; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Parenteau M; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Syngal S; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Bae E; University of Pennsylvania, Philadelphia, PA 19104, USA.
Bickmore T; Northeastern University, 360 Huntington Ave, Boston, MA 02115, USA.
Hampel H; City of Hope, 1500 E Duarte Rd, Duarte, CA 91010, USA.
Idos GE; City of Hope, 1500 E Duarte Rd, Duarte, CA 91010, USA.
Parmigiani G; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.
Yurgelun MB; Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA 02115, USA.
Braun D; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

Cancers (Basel) ; 15(2)2023 Jan 06.

Article em En | MEDLINE | ID: mdl-36672340

Palavras-chave

Lynch Syndrome (LS); cancer penetrance; cancer risk; cascade testing; clinical decision support (CDS) tool; genetic counseling; genetically-guided personalized medicine (GPM); germline genetic testing; intervention; risk communication

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google